Article Text

AB0009 Gender-associated differences of dectin-2, dc-sign and mcp-1 polymorphisms in the susceptibility to rheumatoid arthritis
  1. L. M. Canet1,
  2. R. Cáliz2,
  3. C. Lupiañez1,
  4. A. Escudero3,
  5. I. Filipescu4,
  6. L. Romani2,
  7. J. Segura-Catena1,
  8. M. J. Soto-Pino2,
  9. M. Expósito-Ruiz5,
  10. M. A. Ferrer2,
  11. A. García2,
  12. A. González-Utrilla2,
  13. T. Vallejo2,
  14. K. Hemminki6,7,
  15. A. Försti6,7,
  16. E. Collantes3,
  17. J. Sainz1,7
  1. 1Genomic Oncology, GENYO (Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government)
  2. 2Rheumatology department, Virgen de las Nieves University Hospital, Granada
  3. 3Rheumatology department, Reina Sofía Hospital, Cordoba, Spain
  4. 4Rheumatology Department, University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania
  5. 5FIBAO Fundation, Virgen de las Nieves University Hospital, Granada, Spain
  6. 6Center for Primary Health Care Research, Clinical Research Center, Malmö, Sweden
  7. 7Division of Molecular Genetic Epidemiology, German Cancer Research, Heidelberg, Germany


Background Hormonal, environmental and genetic factors interact in the development of rheumatoid arthritis (RA) but it is still not clear which factors are responsible for the observed gender associated differences in RA incidence and severity. Given that the invasion of RA synovial by macrophages (and subsequently by T-cells) is a critical step that requires the involvement of several immune molecules and given the role of genetic variants in determining the immune response, the present study was conducted to explore whether single nucleotide polymorphisms in immune-related genes might differentially influence the risk of RA in women and men.

Methods Twenty-seven functional/tagging polymorphisms in Dectin-1, Dectin-2, DC-SIGN, MCP-1 and CCR2 genes were selected and genotyped in 970 individuals, 458 RA patients (359 women and 99 men) and 512 healthy controls (217 women and 295 men).

Results We found that women carrying the Dectin-2rs4264222_T and Dectin-2rs7134303_G alleles had an increased risk of RA (OR=1.95, 95%CI 1.35-2.82 and OR=1.91, 95%CI 1.29-2.83) whereas women carrying the MCP-1rs1024611_G, and MCP-1rs13900_C alleles had a decreased risk of RA compared with those carrying the wild-type genotype (OR=0.60, 95%CI 0.42-0.86 and OR=0.65, 95%CI 0.46-0.93). In men, none of these associations were observed but we found that carriers of the DC-SIGNrs2287886_A allele had an increased risk of RA (OR=1.69, 95%CI 1.03-2.78) whereas carriers of the DC-SIGNrs4804803_G had a decreased risk of developing the disease (OR=0.54, 95%CI 0.32-0.91). SNP-SNP interaction analysis showed significant three- and four-locus interaction models in women that were not seen in men. Across all these models, the most accurate predictor was a model that consisted of DC-SIGNrs4804803, Dectin-2rs4264222 and Dectin-2rs7134303 polymorphisms and suggested a synergistic effect between Dectin-2rs7134303 and Dectin-2rs4264222.

Conclusions These results suggest that Dectin-2, MCP-1 and DC-SIGN polymorphisms may account for gender-associated differences in susceptibility to RA. Future studies in larger populations are needed to corroborate our findings.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.